Does consolidation with autologous stem cell transplantation improve the outcome of children with metastatic or relapsed ewing sarcoma?

Pediatric Blood and Cancer

Volumn 49, Issue 2, 2007, Pages 190-195

  Al Faris, Nafisah ^a   Al Harbi, Talal ^a   Goia, Cristina ^a   Pappo, Alberto ^a   Doyle, John ^a   Gassas, Adam ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Autologous stem cell transplantation; Ewing sarcoma; Metastatic

Indexed keywords

AMIFOSTINE; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; BUSULFAN; CARBOPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; EXATECAN; FLUCONAZOLE; GRANULOCYTE COLONY STIMULATING FACTOR; IFOSFAMIDE; IMMUNOGLOBULIN; MELPHALAN; PENICILLIN DERIVATIVE; TOPOTECAN; VINCRISTINE;

ADOLESCENT; ANAPHYLAXIS; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BONE METASTASIS; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER SURGERY; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; CYTOMEGALOVIRUS INFECTION; DISEASE COURSE; DISEASE FREE SURVIVAL; EWING SARCOMA; FEBRILE NEUTROPENIA; FEMALE; FOLLOW UP; HUMAN; LUNG METASTASIS; MALE; METASTASIS; MULTIPLE CYCLE TREATMENT; MYCOSIS; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; REMISSION; STREPTOCOCCUS INFECTION; TREATMENT OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE NEOPLASMS; CAMPTOTHECIN; CARBOPLATIN; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; DISEASE-FREE SURVIVAL; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; FOLLOW-UP STUDIES; HUMANS; IFOSFAMIDE; INFECTION CONTROL; KAPLAN-MEIERS ESTIMATE; MELPHALAN; NEOPLASM RECURRENCE, LOCAL; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; POSTOPERATIVE CARE; RETROSPECTIVE STUDIES; RISK; SALVAGE THERAPY; SARCOMA, EWING'S; TOPOTECAN; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, AUTOLOGOUS; TREATMENT FAILURE; VINCRISTINE;

EID: 34447288269     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21140     Document Type: Article

References (41)

1. Laws HJ, Burdach S, van KB, et al. Multimodality diagnostics and megatherapy in poor prognosis Ewing's tumor patients. A single-center report. Strahlenther Onkol 1999;175:488-494.
2. Tanaka K, Matsunobu T, Sakamoto A, et al. High-dose chemotherapy and autologous peripheral blood stem-cell transfusion after conventional chemotherapy for patients with high-risk Ewing's tumors. J Orthop Sci 2002;7:477-482.
3. Cotterill SJ, Ahrens S, Paulussen M, et al. Prognostic factors in Ewing's tumor of bone: Analysis of 975 patients from the European Intergroup Cooperative Ewing's Sarcoma Study Group. J Clin Oncol 2000;18:3108-3114.
4. Cangir A, Vietti TJ, Gehan EA, et al. Ewing's sarcoma metastatic at diagnosis. Results and comparisons of two intergroup Ewing's sarcoma studies. Cancer 1990;66:887-893.
5. Kalambakas SA, Moore TB, Feig SA. Megatherapy and stem cell transplantation for Ewing's family of tumors: A critical review of current literature. Pediatr Transplant 2004;8:83-88.
6. Rodriguez-Galindo C, Billups CA, Kun LE, et al. Survival after recurrence of Ewing tumors: The St. Jude Children's Research Hospital experience, 1979-1999. Cancer 2002;94:561-569.
7. Horowitz ME, alawer MM, Yoo SY. Ewing's sarcoma family of tumors: Ewing's sarcoma of bone and soft tissue and the peripheral primitive neuroectodermal tumors. In: Pizzo P, Poplack DG, editors. Principles and practice of pediatric oncology. 3rd edition. Philadelphia: Lippincott; 1997. pp 831-863.
8. Burdach S, Jurgens H, Peters C, et al. Myeloablative radiochemotherapy and hematopoietic stem-cell rescue in poor-prognosis Ewing's sarcoma. J Clin Oncol 1993;11:1482-1488.
9. Bessa E, Oberlin O, Brunat-Mentigny M. Sixty-three relapses of localized Ewing's sarcoma: Prognosis and outcome. Med Pediatr Oncol 1996; 27-572.
10. Meyers PA. High-dose therapy with autologous stem cell rescue for pediatric sarcomas. Curr Opin Oncol 2004;16:120-125.
11. Peter M, Magdelenat H, Michon J, et al. Sensitive detection of occult Ewing's cells by the reverse transcriptase-polymerase chain reaction. Br J Cancer 1995;72:96-100.
12. Burdach S, Jurgens H. High-dose chemoradiotherapy (HDC) in the Ewing family of tumors (EFT). Crit Rev Oncol Hematol 2002;41:169-189.
13. Berry MP, Jenkin RD, Harwood AR, et al. Ewing's sarcoma: A trial of adjuvant chemotherapy and sequential half-body irradiation. Int J Radiat Oncol Biol Phys 1986;12:19-24.
14. Cornbleet MA, Corringham RE, Prentice HG, et al. Treatment of Ewing's sarcoma with high-dose melphalan and autologous bone marrow transplantation. Cancer Treat Rep 1981;65:241-244.
15. Evans RG, Burgert EO, Gilchrist GS, et al. Sequential half-body irradiation (SHBI) and combination chemotherapy as salvage treatment for failed Ewing's sarcoma - A pilot study. Int J Radiat Oncol Biol Phys 1984;10:2363-2368.
16. Kinsella TJ, Mitchell JB, McPherson S, et al. In vitro radiation studies on Ewing's sarcoma cell lines and human bone marrow: Application to the clinical use of total body irradiation (TBI). Int J Radiat Oncol Biol Phys 1984;10:1005-1011.
17. Lucidarme N, Valteau-Couanet D, Oberlin O, et al. Phase II study of high-dose thiotepa and hematopoietic stem cell transplantation in children with solid tumors. Bone Marrow Transplant 1998;22:535-540.
18. Hartmann O, Oberlin O, Beaujean F, et al. Role of high-dose chemotherapy followed by bone marrow autograft in the treatment of metastatic Ewing's sarcoma in children. Bull Cancer 1990;77:181-187.
19. Hawkins D, Barnett T, Bensinger W, et al. Busulfan, melphalan, and thiotepa with or without total marrow irradiation with hematopoietic stem cell rescue for poor-risk Ewing-Sarcoma-Family tumors. Med Pediatr Oncol 2000;34:328-337.
20. Kinsella TJ, Glaubiger D, Diesseroth A, et al. Intensive combined modality therapy including low-dose TBI in high-risk Ewing's Sarcoma Patients. Int J Radiat Oncol Biol Phys 1983;9:1955-1960.
21. Ladenstein R, Lasset C, Pinkerton R, et al. Impact of megatherapy in children with high-risk Ewing's tumours in complete remission: A report from the EBMT Solid Tumour Registry. Bone Marrow Transplant 1995;15:697-705.
22. Pape H, Laws HJ, Burdach S, et al. Radiotherapy and high-dose chemotherapy in advanced Ewing's tumors. Strahlenther Onkol 1999;175:484-487.
23. Atra A, Whelan JS, Calvagna V, et al. High-dose busulphan/melphalan with autologous stem cell rescue in Ewing's sarcoma. Bone Marrow Transplant 1997;20:843-846.
24. Chen AR. High-dose therapy with stem cell rescue for pediatric solid tumors: Rationale and results. Pediatr Transplant 1999;3:78-86.
25. Davies SM, Weigel BJ. High dose busulfan-based chemotherapy with autologous stem cell transplantation (ASCT) for high risk Ewing's sarcoma family of tumors. Am Soc Clin Oncol 2001;364.
26. Frohlich B, Ahrens S, Burdach S, et al. High-dosage chemotherapy in primary metastasized and relapsed Ewing's sarcoma. EICESS Klin Padiatr 1999;211:284-290.
27. Paulussen M, Ahrens S, Burdach S, et al. Primary metastatic (stage IV) Ewing tumor: Survival analysis of 171 patients from the EICESS studies. European Intergroup Cooperative Ewing Sarcoma Studies. Ann Oncol 1998;9:275-281.
28. Valteau-Couanet D, Michon J, Plolivier E. Treatment of metastatic Ewing's sarcomas (ES) with busulfan and melphalan consolidation high dose chemotherapy (HDCT). A study of the French Society of Pediatric Oncology (SFOP). Med Pediatr Oncol 1996;24:238a.
29. Vietti TJ, Gehan EA, Nesbit ME, Jr., et al. Multimodal therapy in metastatic Ewing's sarcoma: An Intergroup Study. Natl Cancer Inst Monogr 1981; 279-284.
30. Kinsella TJ, Miser JS, Waller B, et al. Long-term follow-up of Ewing's sarcoma of bone treated with combined modality therapy. Int J Radiat Oncol Biol Phys 1991;20:389-395.
31. Ladenstein R, Hartmann O, Pinkerton R, et al. A multivariate and matched pair analysis on high risk Ewing tumor patients treated by megatherapy and stem cell reinfusion in Europe. Eur J Cancer 1999; 555.
32. Taeb P, Sharda S, Marcus R. Results of an ablative dose-stem cell rescue protocol for patients with Ewings sarcoma, metastatic at diagnosis: Results of a 20-year experience at the University of Florida. Blood 2000; 423.
33. Craft Aw, cotterill s, Imeson J. Improvement in survival for Ewing's sarcoma by substitution of ifosfamide for cyclophosphamide. Am J Pediatr Hematol Oncol 1993;15:S31-S35.
34. Wessalowski R, Jurgens H, Bodenstein H, et al. Results of treatment of primary metastatic Ewing sarcoma. A retrospective analysis of 48 patients. Klin Padiatr 1988;200:253-260.
35. Shankar AG, Ashley S, Craft AW, et al. Outcome after relapse in an unselected cohort of children and adolescents with Ewing sarcoma. Med Pediatr Oncol 2003;40:141-147.
36. Sandoval C, Meyer WH, Parham DM, et al. Outcome in 43 children presenting with metastatic Ewing sarcoma: The St. Jude Children's Research Hospital experience, 1962 to 1992. Med Pediatr Oncol 1996;26:180-185.
37. Fagnou C, Michon J, Peter M, et al. Presence of tumor cells in bone marrow but not in blood is associated with adverse prognosis in patients with Ewing's tumor. Societe Francaise d'Oncologie Pediatrique. J Clin Oncol 1998;16:1707-1711.
38. Fischmeister G, Zoubek A, Jugovic D, et al. Low incidence of molecular evidence for tumour in PBPC harvests from patients with high risk Ewing tumours. Bone Marrow Transplant 1999;24:405-409.
39. Thomson B, Hawkins D, Felgenhauer J, et al. RT-PCR evaluation of peripheral blood, bone marrow and peripheral blood stem cells in children and adolescents undergoing VACIME chemotherapy for Ewing's sarcoma and alveolar rhabdomyosarcoma. Bone Marrow Transplant 1999;24:527-533.
40. Leung W, Chen AR, Klann RC, et al. Frequent detection of tumor cells in hematopoietic grafts in neuroblastoma and Ewing's sarcoma. Bone Marrow Transplant 1998;22:971-979.
41. Merino ME, Navid F, Christensen BL, et al. Immunomagnetic purging of Ewing's sarcoma from blood and bone marrow: Quantitation by real-time polymerase chain reaction. J Clin Oncol 2001;19:3649-3659.